Published in Obesity (Silver Spring) on December 23, 2010
Healthy lifestyle change and subclinical atherosclerosis in young adults: Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation (2014) 1.34
Habitual fish intake and clinically silent carotid atherosclerosis. Nutr J (2014) 0.80
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans. Sci Rep (2016) 0.78
Endothelial function and serum concentration of toxic metals in frequent consumers of fish. PLoS One (2014) 0.75
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol (2005) 3.21
Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients. Hypertens Res (2010) 2.09
Relationship of metabolic syndrome with pulse pressure in patients with essential hypertension. Am J Hypertens (2007) 2.09
Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens Res (2010) 1.54
Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects. Int J Cardiol (2007) 1.41
Parathyroid hormone is inversely related to endothelin-1 in patients on haemodialysis. Nephrology (Carlton) (2008) 1.40
Subclinical atherosclerosis and fetuin-A plasma levels in essential hypertensive patients. Hypertens Res (2012) 1.40
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Trends in 10-year predicted risk of cardiovascular disease in the United States, 1976 to 2004. Circ Cardiovasc Qual Outcomes (2009) 1.35
Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens (2009) 1.31
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol (2005) 1.30
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium (2006) 1.27
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens (2005) 1.26
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Liver Int (2009) 1.21
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol (2010) 1.15
Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk (2002) 1.11
Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol (2008) 1.10
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. J Biol Chem (2011) 1.07
TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol (2006) 1.06
Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis (2004) 1.05
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels (2007) 1.05
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients. Metabolism (2009) 1.04
Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk. Am J Clin Nutr (2012) 1.04
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis (2005) 1.01
Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients. Nephrol Dial Transplant (2008) 0.98
Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study. J Bone Miner Res (2012) 0.97
Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies. Curr Vasc Pharmacol (2011) 0.96
Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin. Hypertens Res (2007) 0.95
A low resting metabolic rate is associated with metabolic syndrome. Clin Nutr (2007) 0.95
Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease. Neurosci Lett (2004) 0.95
Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Nephrol (2007) 0.94
Inverse relationship between ambulatory arterial stiffness index and glomerular filtration rate in arterial hypertension. Am J Hypertens (2008) 0.94
Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. J Hypertens (2010) 0.93
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study. Diabetes Technol Ther (2009) 0.93
Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation (2013) 0.93
The origin of nephrocalcinosis, Randall's plaque and renal stones: a cell biology viewpoint. Arch Ital Urol Androl (2009) 0.92
The association of microalbuminuria with aortic stiffness is independent of C-reactive protein in essential hypertension. Am J Hypertens (2009) 0.90
Crystals, Randall's plaques and renal stones: do bone and atherosclerosis teach us something? J Nephrol (2004) 0.90
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans. J Am Geriatr Soc (2006) 0.90
Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load. J Clin Lipidol (2012) 0.89
Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients. J Cardiometab Syndr (2007) 0.89
Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. Transplantation (2006) 0.89
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. Nephrol Dial Transplant (2005) 0.88
Oral fat load effects on inflammation and endothelial stress markers in healthy subjects. Heart Vessels (2009) 0.88
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia. Clin Invest Med (2009) 0.88
Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg (2013) 0.88
Unfavourable interaction of microalbuminuria and mildly reduced creatinine clearance on aortic stiffness in essential hypertension. Int J Cardiol (2010) 0.87
Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome. Diabetes Res Clin Pract (2009) 0.87
The regenerative potential of the kidney: what can we learn from developmental biology? Stem Cell Rev (2010) 0.87
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients. Curr Med Res Opin (2009) 0.87
Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. Clin J Am Soc Nephrol (2010) 0.86
Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies. J Am Soc Hypertens (2013) 0.86
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int (2003) 0.86
Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. Am J Hypertens (2006) 0.86
Plasma aldosterone and its relationships with left ventricular mass in essential hypertensive patients with the metabolic syndrome. Am J Hypertens (2008) 0.86
Infective endocarditis due to community-associated methicillin-resistant Staphylococcus aureus in injection drug users may be associated with Panton-Valentine leukocidin-negative strains. Scand J Infect Dis (2007) 0.86
Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients. Expert Opin Biol Ther (2013) 0.85
Genes involved in TGF beta1-driven epithelial-mesenchymal transition of renal epithelial cells are topologically related in the human interactome map. BMC Genomics (2007) 0.85
Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review. Rev Panam Salud Publica (2012) 0.85
Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers. Crit Care Res Pract (2012) 0.85
Glycaemic variability and inflammation in subjects with metabolic syndrome. Acta Diabetol (2008) 0.85
Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes. Endothelium (2007) 0.84
Heparin reduces glomerular infiltration and TGF-beta protein expression by macrophages in puromycin glomerulosclerosis. J Nephrol (2003) 0.84
Dent's disease and prevalence of renal stones in dialysis patients in Northeastern Italy. J Hum Genet (2005) 0.84
ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications. J Nephrol (2010) 0.84
Validation of a food frequency questionnaire for use in Italian adults living in Sicily. Int J Food Sci Nutr (2015) 0.83
Decorin transfection in human mesangial cells downregulates genes playing a role in the progression of fibrosis. J Clin Lab Anal (2002) 0.83
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha. Hypertens Res (2006) 0.83
Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease. ScientificWorldJournal (2013) 0.83
Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months. Endothelium (2007) 0.83
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load. Eur J Pharmacol (2010) 0.83
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocr J (2010) 0.83
Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency. J Bone Miner Res (2010) 0.82
Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects. Microvasc Res (2010) 0.82
Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease. Int J Mol Med (2004) 0.82
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. J Nephrol (2013) 0.82
Relationships between maximal oxygen uptake and endothelial function in healthy male adults: a preliminary study. Acta Diabetol (2010) 0.82
C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension. J Hypertens (2007) 0.82
Encrusted cystitis by Corynebacterium urealyticum: a case report with novel insights into bladder lesions. Nephrol Dial Transplant (2008) 0.82
Retracted Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study. J Diabetes Complications (2011) 0.82
Effects of nateglinide and glibenclamide on prothrombotic factors in naïve type 2 diabetic patients treated with metformin: a 1-year, double-blind, randomized clinical trial. Intern Med (2007) 0.81
Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects. Microvasc Res (2010) 0.81
Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT. Mediators Inflamm (2012) 0.81
GAPDH as housekeeping gene at renal level. Kidney Int (2004) 0.81